CSTM vs LIN

For growth investors, Constellium SE (CSTM) is the stronger pick with 15.

2% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Constellium SE (CSTM) offers the better valuation at 17. 4x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Constellium SE (CSTM) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Constellium SE (CSTM) is the cheapest at 17.

4x versus Linde plc at 34. 4x. On forward P/E, Constellium SE is actually cheaper at 10. 6x.

Over the past 5 years, Constellium SE (CSTM) delivered a total return of +95.

4%, compared to +78. 1% for Linde plc (LIN). Over 10 years, the gap is even starker: CSTM returned +491. 0% versus LIN's +376. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Constellium SE's 1. 85β — meaning CSTM is approximately 670% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 2% for Constellium SE — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Constellium SE (CSTM) is pulling ahead at 15.

2% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Constellium SE grew EPS 418. 9% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus 3. 2% for Constellium SE — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 5. 6% for CSTM. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Constellium SE (CSTM) trades at 10.

6x forward P/E versus 28. 1x for Linde plc — 17. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 5% to $539. 71.

In this comparison, LIN (1.

2% yield) pays a dividend. CSTM does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). Constellium SE (CSTM) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +376. 9%, CSTM: +491. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CSTM is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. LIN pays a dividend while CSTM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.